News
Quatrefolic® shines at Fetomaternal 2024
20 March 2024
In Indonesia, the use of pregnancy supplements has increased in recent years due to growing awareness of maternal health, often recommended to support fetal development and maternal well-being.
During the recent Fetomaternal event held from 4-5 March 2024, several pharmaceutical companies were present to showcase their pregnancy supplements, with Quatrefolic® gaining traction in the market.
Addressing Quatrefolic® and its advantages during lunch symposium
Quatrefolic®, the bioactive form of folate, has gained popularity in supporting pregnancy in Indonesia.
During the lunch symposium sponsored by PT. Dipa, Prof. Dr. dr. Noroyono Wibowo discussed the topic of Quatrefolic® in preconception and pregnancy for reducing the risk of fetal neural tube defects.
How does Quatrefolic® reduce the risk of fetal neutal tube defects?
During pregnancy, folate plays a critical role in the synthesis of DNA and cell division, especially during the rapid growth of the fetus. Neural tube defects occur when the neural tube, which eventually forms the baby’s brain and spinal cord, does not close properly.
Folate, and especially Quatrefolic® due to its enhanced bioavailability, helps prevent neural tube defects by supporting the closure of the neural tube during early pregnancy.
